Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enovus AAA Endograft Seal Of Approval Sought For Novel O-Ring Design

This article was originally published in The Gray Sheet

Executive Summary

TriVascular's low-profile Enovus could prove an attractive endograft option for women and other patients with small arteries, if the novel design proves safe and effective

You may also be interested in...



Boston Scientific Looks To Endosurgery Division For Future Growth Drivers

Boston Scientific will leverage its position as the number-one seller of endoscopy devices when it rolls out its Endovations system into the estimated $1.5 bil. endoscope market in Q2 2006

Boston Scientific Looks To Endosurgery Division For Future Growth Drivers

Boston Scientific will leverage its position as the number-one seller of endoscopy devices when it rolls out its Endovations system into the estimated $1.5 bil. endoscope market in Q2 2006

Boston Scientific’s TriVascular Stake Gives AAA Market New Entrant

Boston Scientific's investment in abdominal aortic aneurysm device developer TriVascular, Inc., with an option to buy, shows the company is following through on its promise to become a significant player in the potentially lucrative AAA market

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel